Holger Loessner
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
- Endocrinology top 5%
Papers in
-
- Cancer Research and Treatments 13
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Siegfried WeißKathrin WestphalSara LeschnerJadwiga JabłońskaManfred RohdeSiegfried WeissStefan LienenklausKathrin Wolf
- Journals
- Expert Opinion on Biological Therapy (2 papers)Cellular Microbiology (2 papers)PLoS ONE (2 papers)Microbes and Infection (2 papers)Antibiotics (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Holger Loessner
18 papers receiving 896 citations
Peers
Comparison fields: 5 of 72
- Biotechnology 514
- Endocrinology 83
- Genetics 328
- Biomedical Engineering 377
- Molecular Medicine 42
Countries citing papers authored by Holger Loessner
This map shows the geographic impact of Holger Loessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Loessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Loessner more than expected).
Fields of papers citing papers by Holger Loessner
This network shows the impact of papers produced by Holger Loessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Loessner. The network helps show where Holger Loessner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Holger Loessner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 5 | |
| 2 | 2019 | 23 | |
| 3 | 2017 | 127 | |
| 4 | 2014 | 8 | |
| 5 | 2014 | 19 | |
| 6 | 2012 | 30 | |
| 7 | Towards in vitro potency testing of inactivated erysipelas vaccines. | 2012 | 1 |
| 8 | 2011 | 41 | |
| 9 | 2011 | 40 | |
| 10 | 2011 | 41 | |
| 11 | 2009 | 43 | |
| 12 | 2009 | 183 | |
| 13 | 2008 | 156 | |
| 14 | 2007 | 87 | |
| 15 | 2007 | 29 | |
| 16 | 2006 | 16 | |
| 17 | 2004 | 4 | |
| 18 | 2004 | 57 |
About Holger Loessner
Holger Loessner is a scholar working on Biotechnology, Molecular Medicine, Genetics, Ecology and Microbiology, having authored 18 papers that have together received 910 indexed citations. Recurring topics across this work include Cancer Research and Treatments (13 papers), Virus-based gene therapy research (7 papers), Bacteriophages and microbial interactions (6 papers), Nanoplatforms for cancer theranostics (5 papers), Bacterial biofilms and quorum sensing (4 papers), Bacterial Genetics and Biotechnology (2 papers), CRISPR and Genetic Engineering (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Biotechnology (514 citations), Endocrinology (83 citations), Genetics (328 citations), Biomedical Engineering (377 citations) and Molecular Medicine (42 citations). Holger Loessner has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Siegfried Weiß, Kathrin Westphal, Sara Leschner, Jadwiga Jabłońska, Manfred Rohde, Siegfried Weiss, Stefan Lienenklaus, Kathrin Wolf, Nelson O. Gekara and Marcin Łyszkiewicz. Their work appears in journals such as Expert Opinion on Biological Therapy, Cellular Microbiology, PLoS ONE, Microbes and Infection and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.